These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21378963)

  • 1. Structure of the VP16 transactivator target in the Mediator.
    Milbradt AG; Kulkarni M; Yi T; Takeuchi K; Sun ZY; Luna RE; Selenko P; Näär AM; Wagner G
    Nat Struct Mol Biol; 2011 Apr; 18(4):410-5. PubMed ID: 21378963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR structure of the human Mediator MED25 ACID domain.
    Bontems F; Verger A; Dewitte F; Lens Z; Baert JL; Ferreira E; de Launoit Y; Sizun C; Guittet E; Villeret V; Monté D
    J Struct Biol; 2011 Apr; 174(1):245-51. PubMed ID: 20974256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and VP16 binding of the Mediator Med25 activator interaction domain.
    Vojnic E; Mourão A; Seizl M; Simon B; Wenzeck L; Larivière L; Baumli S; Baumgart K; Meisterernst M; Sattler M; Cramer P
    Nat Struct Mol Biol; 2011 Apr; 18(4):404-9. PubMed ID: 21378965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction studies of the human and Arabidopsis thaliana Med25-ACID proteins with the herpes simplex virus VP16- and plant-specific Dreb2a transcription factors.
    Aguilar X; Blomberg J; Brännström K; Olofsson A; Schleucher J; Björklund S
    PLoS One; 2014; 9(5):e98575. PubMed ID: 24874105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solution NMR structure of MED25(391-543) comprising the activator-interacting domain (ACID) of human mediator subunit 25.
    Eletsky A; Ruyechan WT; Xiao R; Acton TB; Montelione GT; Szyperski T
    J Struct Funct Genomics; 2011 Sep; 12(3):159-66. PubMed ID: 21785987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Basis for the Interaction between p53 Transactivation Domain and the Mediator Subunit MED25.
    Lee MS; Lim K; Lee MK; Chi SW
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30360415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of ERM transactivation domain binding to the ACID/PTOV domain of the Mediator subunit MED25.
    Landrieu I; Verger A; Baert JL; Rucktooa P; Cantrelle FX; Dewitte F; Ferreira E; Lens Z; Villeret V; Monté D
    Nucleic Acids Res; 2015 Aug; 43(14):7110-21. PubMed ID: 26130716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMR structure of the complex between the Tfb1 subunit of TFIIH and the activation domain of VP16: structural similarities between VP16 and p53.
    Langlois C; Mas C; Di Lello P; Jenkins LM; Legault P; Omichinski JG
    J Am Chem Soc; 2008 Aug; 130(32):10596-604. PubMed ID: 18630911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory Syncytial Virus NS1 Protein Targets the Transactivator Binding Domain of MED25.
    Dong J; Basse V; Bierre M; Peres de Oliveira A; Vidalain PO; Sibille P; Tangy F; Galloux M; Eleouet JF; Sizun C; Bajorek M
    J Mol Biol; 2022 Oct; 434(19):167763. PubMed ID: 35907573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Mediator complex subunit MED25 is targeted by the N-terminal transactivation domain of the PEA3 group members.
    Verger A; Baert JL; Verreman K; Dewitte F; Ferreira E; Lens Z; de Launoit Y; Villeret V; Monté D
    Nucleic Acids Res; 2013 May; 41(9):4847-59. PubMed ID: 23531547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The VP16 activation domain establishes an active mediator lacking CDK8 in vivo.
    Uhlmann T; Boeing S; Lehmbacher M; Meisterernst M
    J Biol Chem; 2007 Jan; 282(4):2163-73. PubMed ID: 17135252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in determinants required for complex formation and transactivation in related VP16 proteins.
    Grapes M; O'Hare P
    J Virol; 2000 Nov; 74(21):10112-21. PubMed ID: 11024140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activator-recruited cofactor/Mediator coactivator subunit ARC92 is a functionally important target of the VP16 transcriptional activator.
    Yang F; DeBeaumont R; Zhou S; Näär AM
    Proc Natl Acad Sci U S A; 2004 Feb; 101(8):2339-44. PubMed ID: 14983011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple hTAF(II)31-binding motifs in the intrinsically unfolded transcriptional activation domain of VP16.
    Kim DH; Lee SH; Nam KH; Chi SW; Chang I; Han KH
    BMB Rep; 2009 Jul; 42(7):411-7. PubMed ID: 19643037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivalent and Bidirectional Binding of Transcriptional Transactivation Domains to the MED25 Coactivator.
    Jeffery HM; Weinzierl ROJ
    Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32825095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional activation by DNA-binding derivatives of HSV-1 VP16 that lack the carboxyl-terminal acidic activation domain.
    Popova B; Bilan P; Xiao P; Faught M; Capone JP
    Virology; 1995 May; 209(1):19-28. PubMed ID: 7747469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino acid substitutions in the herpes simplex virus transactivator VP16 uncouple direct protein-protein interaction and DNA binding from complex assembly and transactivation.
    Shaw P; Knez J; Capone JP
    J Biol Chem; 1995 Dec; 270(48):29030-7. PubMed ID: 7499437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural properties of the promiscuous VP16 activation domain.
    Jonker HR; Wechselberger RW; Boelens R; Folkers GE; Kaptein R
    Biochemistry; 2005 Jan; 44(3):827-39. PubMed ID: 15654739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The extreme carboxyl terminus of the equine herpesvirus 1 homolog of herpes simplex virus VP16 is essential for immediate-early gene activation.
    Elliott GD
    J Virol; 1994 Aug; 68(8):4890-7. PubMed ID: 8035487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VP16-dependent association of chromatin-modifying coactivators and underrepresentation of histones at immediate-early gene promoters during herpes simplex virus infection.
    Herrera FJ; Triezenberg SJ
    J Virol; 2004 Sep; 78(18):9689-96. PubMed ID: 15331701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.